Oral blood pressure augmenting agents for intravenous vasopressor weaning

doi:10.12998/wjcc.v12.i36.6892

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 36

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (566)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

303

Figures (1-1)

Tables (1-2)

Sum=420

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=103

Publishing Process of This Article

Item

Count

Browse

Download

Sum=26

Dec 26, 2024 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Cases. Dec 26, 2024; 12(36): 6892-6904
Published online Dec 26, 2024. doi: 10.12998/wjcc.v12.i36.6892

Full Size Figure Download Figure

Figure 1 Oral blood pressure augmenting agents’ mechanism of action. A₁: Alpha₁; AADC: Aromatic amino acid decarboxylase; ADP: Adenosine diphosphate; ATP: Adenosine triphosphate; Ca²⁺: Calcium cation; DAG: Diacylglycerol; DG: Deglycination; IP₃: Inositol-1,4,5-triphosphate; MLC: Myosin light chain; MLCK: Myosin light chain kinase; MLCP: Myosin light chain phosphatase; P: Phosphorus; PIP₂: Phosphatidylinositol-4,5-bisphosphate; PLC: Phospholipase C; SR: Sarcoplasmic reticulum.

Citation: Robinson JC, ElSaban M, Smischney NJ, Wieruszewski PM. Oral blood pressure augmenting agents for intravenous vasopressor weaning. World J Clin Cases 2024; 12(36): 6892-6904
URL: https://www.wjgnet.com/2307-8960/full/v12/i36/6892.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i36.6892